SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth
Hélène Berger(University of Geneva), Lionel Apétoh(Indiana University Health)
Cited by 52
Related Papers
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
|Annals of Oncology|2015|284
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T<sub>H</sub>1 and T<sub>H</sub>9 cells
|Journal for ImmunoTherapy of Cancer|2022|79
Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
|Cells|2020|11
CASM potentiates STING-driven NFκB signaling in immune cells
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0